Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

A Combination of CD302 gene Expression and 3-Months BCR-ABL1 Level Predicts Inferior Achievement of Deep Molecular Response in CP-CML Patients Treated with Imatinib

Chung Hoow Kok, PhD BSc, Liu Liu, PhD BSc, David T Yeung, PhDBSc,FRACP,FRCPA,MBBS, Verity A Saunders, Phuong Dang, Timothy P. Hughes, MDMBBS,FRACP,FRCPA

Blood (2019) 134 (Supplement_1): 663.

https://doi.org/10.1182/blood-2019-125446

Published: 2019

Journal Articles

An Open Label Study of Alpn-101, a First-in-Class Dual CD28/ICOS Antagonist, in Subjects with Steroid-Resistant or Steroid-Refractory Acute Graft Versus Host Disease (aGVHD)

Jing Yang, PhD, Jan L. Hillson, MD, Kristi L. Manjarrez, Jennifer R. Wiley, DRSc, Gary D. Means, PhD, Stacey R. Dillon, PhD, Stanford L. Peng, MD,PhD

Blood (2019) 134 (Supplement_1): 372.

https://doi.org/10.1182/blood-2019-126034

Published: 2019

Journal Articles

Bispecific T-Cell Engager (BiTE) Antibody Based Immunotherapy for Treatment of Relapsed Refractory Multiple Myeloma (RRMM): A Systematic Review of Preclinical and Clinical Trials

Zunairah Shah, MBBS, Mustafa Nadeem Malik, MD, Syeda Sabeeka Batool, MBBS, MD, Sravanthi Kotapati, MBBS, Aisha Akhtar, MBBS, Owais ur Rehman, MBBS, Marium Ghani, MBBS, Maryam Sadiq, MBBS, Arshia Akbar, MD, Aqsa Ashraf, MBBS, Arafat Ali Ali Farooqui, MD, Muhammad Abdullah Yousaf, MBBS, MD, Muhaddis Ejaz Ahmad, MD, Hafiz Muhammad Fazeel, MBBS, Faiz Anwer, MD

Blood (2019) 134 (Supplement_1): 5567.

https://doi.org/10.1182/blood-2019-129652

Published: 2019

Journal Articles

Efficacy and Safety of Blinatumomab in Asian Adults with Relapsed/Refractory B-Precursor ALL

Yukio Kobayashi, Iekuni Oh, MD PhD, Toshihiro Miyamoto, MD PhD, Won-Sik Lee, Hiroatsu Iida, MD PhD, Hironobu Minami, MD PhD, Yoshinobu Maeda, MD PhD, Jun Ho Jang, Sung-Soo Yoon, MD PhD, Su-Peng Yeh, MD, Qui Tran, Joan Morris, Janet L. Franklin, Ka-Wing Chong, Hitoshi Kiyoi, MD PhD

Blood (2019) 134 (Supplement_1): 5069.

https://doi.org/10.1182/blood-2019-124582

Published: 2019

Journal Articles

Anti-CD47 Antibody, CC-90002, in Combination with Rituximab in Subjects with Relapsed and/or Refractory Non-Hodgkin Lymphoma (R/R NHL)

Pau Abrisqueta, MD PhD, Juan-Manuel Sancho, MD PhD, Raul Cordoba, MD PhD, Daniel O. Persky, MD, Charalambos Andreadis, MD MSCE, Scott F. Huntington, MD MPH, Cecilia Carpio, MD, Daniel Morillo Giles, MD, Xin Wei, PhD, Ying Fei Li, PhD, Marlene Zuraek, MD, Michael R. Burgess, Kristen Hege, Alejandro Martín, MD PhD

Blood (2019) 134 (Supplement_1): 4089.

https://doi.org/10.1182/blood-2019-125310

Published: 2019

Journal Articles

Role of Acute Myeloid Leukemia Derived-Extracellular Vesicles in Dysregulating Normal Hematopoiesis

Ilaria Laurenzana, PhD, Stefania Trino, PhD, Daniela Lamorte, PhD, Michele Santodirocco, MD, Lazzaro Di Mauro, MD, Borazio Nazario, Antonella Caivano, Luciana De Luca, Pellegrino Musto, MD

Blood (2019) 134 (Supplement_1): 1411.

https://doi.org/10.1182/blood-2019-125544

Published: 2019

Journal Articles

The Prognostic Significance of Soluble Interleukin-2-Receptor, Beta-2-Microgrobulin and Serum Albumin in Patient with Diffuse Large B-Cell Lymphoma in the Rituximab Era

Norihito Inoue, MD, Masahiro Yokoyama, MD, Yuko Shirouchi, MD, Takanori Fukuta, MD, Anna Nishihara, MD, Yoshiharu Kusano, MD, Hideki Uryu, MD, Yuko Mishima, MD PhD, Noriko Nishimura, MD PhD, Naoko Tsuyama, MD PhD, Kengo Takeuchi, MD PhD, Yasuhito Terui, MD PhD

Blood (2018) 132 (Supplement 1): 4242.

https://doi.org/10.1182/blood-2018-99-115863

Published: 2018

Journal Articles

Splenic B-Cell Lymphoma/Leukemia, Unclassifiable in Japan

Takaharu Suzuki, MD, Hiroaki Miyoshi, MD PhD, Keisuke Kawamoto, MD PhD, Joji Shimono, MD PhD, Jun Takizawa, MD PhD, Masao Seto, MD PhD, Koichi Ohshima, MD PhD

Blood (2018) 132 (Supplement 1): 5301.

https://doi.org/10.1182/blood-2018-99-113239

Published: 2018

Journal Articles

An Unbalanced Monocyte Macrophage Polarization in the Bone Marrow Microenvironment of Patients with Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation

Hong-Yan Zhao, Song Yang, Ting-Ting Han, Qi Wen, Min-Min Shi, Yu Wang, Lan-Ping Xu, Xiaohui Zhang, MD, Xiao-Jun Huang, MD, Yuan Kong

Blood (2017) 130 (Supplement 1): 3563.

https://doi.org/10.1182/blood.V130.Suppl_1.3563.3563

Published: 2017

Journal Articles

CD30 Expression in Patients with Chronic Myelomonocytic Leukemia

Aref Al-Kali, MD, Patricia Greipp, DO, Mrinal M. Patnaik, MDMBBS, Naseema Gangat, MBBS, Kebede H. Begna, MD, Hassan B. Alkhateeb, MD, Michelle A. Elliott, MD, William J. Hogan, MBBCh, Mark R. Litzow, MD, Phuong Nguyen, MD, Rong He, MD

Blood (2017) 130 (Supplement 1): 5294.

https://doi.org/10.1182/blood.V130.Suppl_1.5294.5294

Published: 2017

Journal Articles

Cumulative D-Index Predicts the Duration of Febrile Neutropenia in AML Patients

Hiroyuki Kubo, Osamu Imataki, Shumpei Uchida, Shigeyuki Yokokura, Makiko Uemura, Norimitsu Kadowaki, MD PhD

Blood (2016) 128 (22): 5180.

https://doi.org/10.1182/blood.V128.22.5180.5180

Published: 2016

Journal Articles

Phenotypic Characteristics of Tumor Cells in Patients with Chronic Lymphocytic Leukemia into Different Prognostic Groups

Aleksei Kuvshinov, Sergei Voloshin, Irina Martynkevich, MD PhD, Ludmila Martynenko, Andrei Garifullin, Elizaveta Kleina, Kudrat Abdulkadyrov

Blood (2015) 126 (23): 5276.

https://doi.org/10.1182/blood.V126.23.5276.5276

Published: 2015

Journal Articles

N-Glycoproteomic Landscape of Human Lymphoid Cancers Reveals Novel Biomarkers and Potential Therapeutic Targets

Delphine CM Rolland, Pharm D, PhD, Venkatesha Basrur, PhD, Yoon Kyung Jeon, MD PhD, Carla McNeil-Schwalm, MD, Damian Fermin, PhD, Kevin Conlon, MS, Chih-Chiang Tsou, PhD, Noah A Brown, MD, Dafydd G Thomas, MD PhD, Nathanael G. Bailey, MD, Gilbert S Omenn, MD PhD, Alexey I Nesvizhskii, PhD, Megan S Lim, MD PhD, Kojo SJ Elenitoba-Johnson, MD

Blood (2015) 126 (23): 697.

https://doi.org/10.1182/blood.V126.23.697.697

Published: 2015

Journal Articles

Cytometric Response in Multiple Myeloma Cells to Low and Standard Doses of Bortezomib

Nicole Beffermann, MD, Mauricio Ocqueteau, MD, Pablo Ramirez, MD, Mauricio Galleguillos, MSC, Mauricio Sarmiento, PhD

Blood (2015) 126 (23): 5393.

https://doi.org/10.1182/blood.V126.23.5393.5393

Published: 2015

Journal Articles

Lineage-Specific Chimerism Monitoring Using Flow Cytometry with Anti HLA-Antibodies in Haploidentical Hematopoietic Stem Cell Transplantation

Bo Hyun Kim, MD, Seongsoo Jang, MD PhD, Yu-jin Lee, Nuree Park, Young-Uk Cho, MD PhD, Chan-Jeoung Park, MD PhD, Eun-Seok Choi, Jin-Kyung Seo, Seong-Uk Lee, Kyung-Nam Koh, MD PhD, Ho Joon Im, MDPhD, Jong Jin Seo, MD

Blood (2014) 124 (21): 3921.

https://doi.org/10.1182/blood.V124.21.3921.3921

Published: 2014

Journal Articles

The Detection Of The Immunophenotyping Of Plasma Cells In Patients With Multiple Myeloma

Jian Ouyang, MD, Ermin Li, Min Zhou, Junhao Chen, Yongquan Xia, Xuejing Xu, Xian Wang, Rong-Fu Zhou, MD

Blood (2013) 122 (21): 5335.

https://doi.org/10.1182/blood.V122.21.5335.5335

Published: 2013

Journal Articles

Lost in Post-Translation, Found by Mass Spectrometry: Identification of Novel Biomarkers and Biologic Insights in Lymphoma Pathogenesis

Kojo S.J. Elenitoba-Johnson, MD

Blood (2013) 122 (21): SCI-23.

https://doi.org/10.1182/blood.V122.21.SCI-23.SCI-23

Published: 2013

Journal Articles

Normal Values for High Affinity Fc Gamma Receptor I (CD64) From Neonate to Young Adults

Shoko Matsushita, Yoshiko Asakura, Yuko Hayashi, Mikiya Endo, MD, Yukie Nakatsuji, Shigeki Ito, MD, PhD

Blood (2012) 120 (21): 4685.

https://doi.org/10.1182/blood.V120.21.4685.4685

Published: 2012

Journal Articles

The Cellular Classification and Separation of Nucleated Blood Cells by Supravital Cell Staining with Acridine Orange

Sayaka Kinoshita, BSc, Yutaka Nagai, BSc, MSc, DSc, Yuta Tanizaki, BSc, MSc, Takashi Kato, BSc, MSc, DSc

Blood (2011) 118 (21): 4907.

https://doi.org/10.1182/blood.V118.21.4907.4907

Published: 2011

Journal Articles

Surface Antigens Identified by Antibody Microarray That Correlate with IgV H Mutational Status and ZAP70 Expression in CLL.

William G. Wierda, MD, PhD, S. Mulligan, MD, B. Shelvin, L. Belov, PhD, L. Rassenti, PhD, T. Kipps, MD, PhD, S. Lerner, MS, M. Thomas, PhD, H. Kantarjian, MD, M. Keating, MB, BS

Blood (2005) 106 (11): 2944.

https://doi.org/10.1182/blood.V106.11.2944.2944

Published: 2005

NARROW

A Combination of CD302 gene Expression and 3-Months BCR-ABL1 Level Predicts Inferior Achievement of Deep Molecular Response in CP-CML Patients Treated with Imatinib

An Open Label Study of Alpn-101, a First-in-Class Dual CD28/ICOS Antagonist, in Subjects with Steroid-Resistant or Steroid-Refractory Acute Graft Versus Host Disease (aGVHD)

Bispecific T-Cell Engager (BiTE) Antibody Based Immunotherapy for Treatment of Relapsed Refractory Multiple Myeloma (RRMM): A Systematic Review of Preclinical and Clinical Trials

Efficacy and Safety of Blinatumomab in Asian Adults with Relapsed/Refractory B-Precursor ALL

Anti-CD47 Antibody, CC-90002, in Combination with Rituximab in Subjects with Relapsed and/or Refractory Non-Hodgkin Lymphoma (R/R NHL)

Role of Acute Myeloid Leukemia Derived-Extracellular Vesicles in Dysregulating Normal Hematopoiesis

The Prognostic Significance of Soluble Interleukin-2-Receptor, Beta-2-Microgrobulin and Serum Albumin in Patient with Diffuse Large B-Cell Lymphoma in the Rituximab Era

Splenic B-Cell Lymphoma/Leukemia, Unclassifiable in Japan

An Unbalanced Monocyte Macrophage Polarization in the Bone Marrow Microenvironment of Patients with Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation

CD30 Expression in Patients with Chronic Myelomonocytic Leukemia

Cumulative D-Index Predicts the Duration of Febrile Neutropenia in AML Patients

Phenotypic Characteristics of Tumor Cells in Patients with Chronic Lymphocytic Leukemia into Different Prognostic Groups

N-Glycoproteomic Landscape of Human Lymphoid Cancers Reveals Novel Biomarkers and Potential Therapeutic Targets

Cytometric Response in Multiple Myeloma Cells to Low and Standard Doses of Bortezomib

Lineage-Specific Chimerism Monitoring Using Flow Cytometry with Anti HLA-Antibodies in Haploidentical Hematopoietic Stem Cell Transplantation

The Detection Of The Immunophenotyping Of Plasma Cells In Patients With Multiple Myeloma

Lost in Post-Translation, Found by Mass Spectrometry: Identification of Novel Biomarkers and Biologic Insights in Lymphoma Pathogenesis

Normal Values for High Affinity Fc Gamma Receptor I (CD64) From Neonate to Young Adults

The Cellular Classification and Separation of Nucleated Blood Cells by Supravital Cell Staining with Acridine Orange

Surface Antigens Identified by Antibody Microarray That Correlate with IgV H Mutational Status and ZAP70 Expression in CLL.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only